Roelof Rongen's most recent trade in GRI Bio Inc was a trade of 5,994 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GRI Bio Inc | Roelof Rongen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 5,994 | 5,994 | - | - | Stock Option (Right to Buy) | |
| GRI Bio Inc | Roelof Rongen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 4,527 | 4,527 | - | - | Stock Option (Right to Buy) | |
| GRI Bio Inc | Roelof Rongen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 30,297 | 30,297 | - | - | Stock Option (Right to Buy) | |
| GRI Bio Inc | Roelof Rongen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 34,483 | 34,483 | - | - | Stock Option (Right to Buy) |